Answer
Periodic monitoring of liver function and hepatitis B viral replication is recommended after stopping Kivexa in patients with HIV and hepatitis B coinfection because withdrawal of lamivudine may cause an acute exacerbation of hepatitis.
Sources for this answer
- Kivexa 600 mg/300 mg film-coated tabletsViiV Healthcare UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 43Document updated
Sources checked